CRO · Private company
ICON plc
Track this companyFree. Adds ICON plc to your Dealase workspace and tells you when its record changes.
Clinical trials2515 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials25
- A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast CancerPHASE3 · RECRUITING · started Jun 15, 2026ClinicalTrials.gov NCT07647328 · fetched Nov 12, 2026
- Open Label Extension to Assess Long Term Safety and Efficacy of KL1333 in Patients With Primary Mitochondrial DiseasePHASE2 · RECRUITING · started Jun 12, 2026ClinicalTrials.gov NCT07514338 · fetched Nov 12, 2026
- A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus ErythematosusPHASE3 · RECRUITING · started Apr 13, 2026ClinicalTrials.gov NCT07430306 · fetched Nov 12, 2026
- Comparability Trial of the MVA-BN Vaccine Manufactured in Different Production CellsPHASE2 · ACTIVE_NOT_RECRUITING · started Oct 27, 2025ClinicalTrials.gov NCT07199569 · fetched Nov 12, 2026
- A Study to Learn About the Safety and Effects of the Study Drug PRX-102 in Children and Adolescents With Fabry DiseasePHASE2_PHASE3 · RECRUITING · started Jul 29, 2025ClinicalTrials.gov NCT06328608 · fetched Nov 12, 2026
- Maternal and Postnatal Outcomes Study (MOS): A Global Observational Registry Assessing the Safety of Elfabrio® in Women With Fabry Disease and Their Infants During Pregnancy and BreastfeedingRECRUITING · started May 23, 2025ClinicalTrials.gov NCT06941025 · fetched Nov 12, 2026
- A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE)PHASE3 · RECRUITING · started Dec 12, 2024ClinicalTrials.gov NCT06716606 · fetched Nov 12, 2026
- Evaluating Technologies for Point-of-Care Blood Collections by PatientsNA · COMPLETED · started Oct 29, 2024ClinicalTrials.gov NCT06507566 · fetched Nov 12, 2026
- Registry Study to Observe Long-term Safety of Vamorolone (AGAMREE®) in Patients With Duchenne Muscular Dystrophy-SUMMITRECRUITING · started Sep 25, 2024ClinicalTrials.gov NCT06564974 · fetched Nov 12, 2026
- A Phase 4 Study to Evaluate Adrenal Function in Hypogonadal Men Treated With JATENZO® for 12 MonthsPHASE4 · COMPLETED · started Jul 2, 2024ClinicalTrials.gov NCT06385509 · fetched Nov 12, 2026
- Non-interventional Study of Patients With Transthyretin (ATTR) AmyloidosisRECRUITING · started Jun 25, 2024ClinicalTrials.gov NCT06465810 · fetched Nov 12, 2026
- A First-in-Human Safety Trial of MTX-463PHASE1 · COMPLETED · started Apr 15, 2024ClinicalTrials.gov NCT06401213 · fetched Nov 12, 2026
- Observational Study Protocol: LIVER-RRECRUITING · started Dec 20, 2023ClinicalTrials.gov NCT06252753 · fetched Nov 12, 2026
- A First-in-Human Study to Evaluate JCXH-105, an SrRNA-based Herpes Zoster VaccinePHASE1 · COMPLETED · started May 26, 2023ClinicalTrials.gov NCT05871541 · fetched Nov 12, 2026
- A Biomarker Screening Protocol for Participants With Solid TumorsTERMINATED · started May 19, 2023ClinicalTrials.gov NCT05891197 · fetched Nov 12, 2026
- A Phase 1 Study to Assess the Safety and Immunogenicity of JCXH-221, an MRNA-based Broadly Protective COVID-19 VaccinePHASE1 · COMPLETED · started Mar 7, 2023ClinicalTrials.gov NCT05743335 · fetched Nov 12, 2026
- US Pivotal Clinical Study of the Adient Absorbable Filter for the Prevention of Pulmonary EmbolismNA · ACTIVE_NOT_RECRUITING · started Jan 27, 2023ClinicalTrials.gov NCT05127915 · fetched Nov 12, 2026
- BXQ-350 in Newly Diagnosed Metastatic Colorectal CarcinomaPHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Jan 9, 2023ClinicalTrials.gov NCT05322590 · fetched Nov 12, 2026
- A Study of XmAb20717 (Vudalimab)in Patients With Selected Advanced Gynecologic and Genitourinary MalignanciesPHASE2 · ACTIVE_NOT_RECRUITING · started Jul 21, 2022ClinicalTrials.gov NCT05032040 · fetched Nov 12, 2026
- ADP-A2M4CD8 in HLA-A2+ Subjects With MAGE-A4 Positive Esophageal or Esophagogastric Junction Cancers (SURPASS-2)PHASE2 · TERMINATED · started Sep 15, 2021ClinicalTrials.gov NCT04752358 · fetched Nov 12, 2026
- ENdoluminal LIGHT ActivatED Treatment of Upper Tract Urothelial Cancer (ENLIGHTED) StudyPHASE3 · ACTIVE_NOT_RECRUITING · started Mar 22, 2021ClinicalTrials.gov NCT04620239 · fetched Nov 12, 2026
- FlowMet-R Blood Flow Measurement for the Diagnosis of Peripheral Artery Disease and Critical Limb IschemiaTERMINATED · started Dec 9, 2019ClinicalTrials.gov NCT04120610 · fetched Nov 12, 2026
- A Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3)PHASE1 · COMPLETED · started May 1, 2019ClinicalTrials.gov NCT03752398 · fetched Nov 12, 2026
- A Safety, Tolerability and Efficacy Study of Sernova's Cell Pouch™ for Clinical Islet TransplantationPHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Feb 7, 2019ClinicalTrials.gov NCT03513939 · fetched Nov 12, 2026
- Plinabulin vs. Pegfilgrastim in Patients With Solid Tumors Receiving Docetaxel Myelosuppressive Chemotherapy Phase 3PHASE3 · COMPLETED · started May 29, 2018ClinicalTrials.gov NCT03102606 · fetched Nov 12, 2026